United Therapeutics (UTHR) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $62.8 million.
- United Therapeutics' Accumulated Depreciation & Amortization rose 1893.94% to $62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.8 million, marking a year-over-year increase of 1893.94%. This contributed to the annual value of $72.5 million for FY2024, which is 3627.82% up from last year.
- Per United Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $62.8 million for Q3 2025, which was up 1893.94% from $40.9 million recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $72.5 million in Q4 2024 and a low of $12.5 million during Q1 2021
- Over the past 5 years, United Therapeutics' median Accumulated Depreciation & Amortization value was $37.3 million (recorded in 2021), while the average stood at $35.9 million.
- Per our database at Business Quant, United Therapeutics' Accumulated Depreciation & Amortization plummeted by 40.0% in 2021 and then skyrocketed by 3627.82% in 2024.
- Quarter analysis of 5 years shows United Therapeutics' Accumulated Depreciation & Amortization stood at $49.9 million in 2021, then increased by 2.81% to $51.3 million in 2022, then rose by 3.7% to $53.2 million in 2023, then skyrocketed by 36.28% to $72.5 million in 2024, then dropped by 13.38% to $62.8 million in 2025.
- Its last three reported values are $62.8 million in Q3 2025, $40.9 million for Q2 2025, and $19.8 million during Q1 2025.